Clinical characteristics of hospitalized patients with metabolic-associated fatty liver disease-related liver cancer: data from a single center, 2010-2019.

Guishuang WangHong ZhaoLei SunGang WanWen Xie

Published in: Therapeutic advances in chronic disease (2023)

MAFLD-related liver cancer should be considered in liver cancer patients with metabolic risk factors. Half of MAFLD-related liver cancer occurred in the absence of cirrhosis.

Keyphrases

risk factors
machine learning
fatty acid
artificial intelligence
drug induced